274 related articles for article (PubMed ID: 30551287)
1. [Eosinophilic granulomatosis with polyangiitis (EGPA) and allergic bronchopulmonary mycosis (ABPM)].
Taniguchi M; Fukutomi Y
Nihon Rinsho; 2016 Oct; 74(10):1721-1728. PubMed ID: 30551287
[TBL] [Abstract][Full Text] [Related]
2. Combined Allergic Bronchopulmonary Aspergillosis and Eosinophilic Granulomatosis with Polyangiitis: Three Cases and a Review of the Literature.
Ishiguro T; Takayanagi N; Takaku Y; Kagiyama N; Kurashima K; Sugita Y
Intern Med; 2016; 55(7):793-7. PubMed ID: 27041167
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship.
Marra AM; Curci P; Franco G; Pittalis G; Tugnoli E; Cavasin D; Cristiano A; Bini F
Cureus; 2024 Apr; 16(4):e57917. PubMed ID: 38601813
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic Granulomatosis with Polyangiitis preceding allergic bronchopulmonary aspergillosis.
Lee W; Teo FS; Santosa A; Teng GG
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):228-31. PubMed ID: 26549342
[TBL] [Abstract][Full Text] [Related]
5. Adult-onset eosinophilic airway diseases.
Asano K; Ueki S; Tamari M; Imoto Y; Fujieda S; Taniguchi M
Allergy; 2020 Dec; 75(12):3087-3099. PubMed ID: 33040364
[TBL] [Abstract][Full Text] [Related]
6. Update on eosinophilic granulomatosis with polyangiitis.
Furuta S; Iwamoto T; Nakajima H
Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
[TBL] [Abstract][Full Text] [Related]
7. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
8. Combined allergic bronchopulmonary mycosis and eosinophilic granulomatosis with polyangiitis: A case report and literature review.
Cui N; Wang J; Shao Y; Zhao J; Cheng Z
Respir Med Case Rep; 2024; 48():102012. PubMed ID: 38545557
[TBL] [Abstract][Full Text] [Related]
9. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
Ennis D; Lee JK; Pagnoux C
Expert Opin Biol Ther; 2019 Jul; 19(7):617-630. PubMed ID: 31146595
[TBL] [Abstract][Full Text] [Related]
10. Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
Berti A; Volcheck GW; Cornec D; Smyth RJ; Specks U; Keogh KA
Respir Med; 2018 Sep; 142():66-72. PubMed ID: 30170804
[TBL] [Abstract][Full Text] [Related]
11. New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group.
Marvisi C; Sinico RA; Salvarani C; Jayne D; Prisco D; Terrier B; Emmi G; Vaglio A;
Intern Emerg Med; 2019 Nov; 14(8):1193-1197. PubMed ID: 31388893
[TBL] [Abstract][Full Text] [Related]
12. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
McBrien CN; Menzies-Gow A
Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of therapeutic activity of mepolizumab.
Cavaliere C; Frati F; Ridolo E; Greco A; de Vincentiis M; Masieri S; Makri E; Incorvaia C
Expert Rev Clin Immunol; 2019 Sep; 15(9):959-967. PubMed ID: 31424304
[No Abstract] [Full Text] [Related]
14. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.
Detoraki A; Tremante E; Poto R; Morelli E; Quaremba G; Granata F; Romano A; Mormile I; Rossi FW; de Paulis A; Spadaro G
Respir Res; 2021 Jun; 22(1):185. PubMed ID: 34162391
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil extracellular traps formation in patients with eosinophilic granulomatosis with polyangiitis: association with eosinophilic inflammation.
Natorska J; Ząbczyk M; Siudut J; Krawiec P; Mastalerz L; Undas A
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):27-32. PubMed ID: 28229830
[TBL] [Abstract][Full Text] [Related]
16. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.
Steinfeld J; Bradford ES; Brown J; Mallett S; Yancey SW; Akuthota P; Cid MC; Gleich GJ; Jayne D; Khoury P; Langford CA; Merkel PA; Moosig F; Specks U; Weller PF; Wechsler ME
J Allergy Clin Immunol; 2019 Jun; 143(6):2170-2177. PubMed ID: 30578883
[TBL] [Abstract][Full Text] [Related]
18. Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis.
Nakamoto K; Saraya T; Ogawa Y; Ishii H; Takizawa H
Respir Med; 2018 Jun; 139():101-105. PubMed ID: 29857992
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study.
Detoraki A; Di Capua L; Varricchi G; Genovese A; Marone G; Spadaro G
J Asthma; 2016; 53(2):201-6. PubMed ID: 26377630
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
Raffray L; Guillevin L
Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
